Dr. David Samadi Advances the Quality of Surgeries

Cancer has now become the most life-threatening disease in the globe. The number of people diagnosed with cancer increases every year. Many medical facilities have therefore tried to come up with therapies that will help patients to cope with their situations and live longer. Dr. David Samadi is one of the most known doctors for their expertise at work. He was born in Iran and raised in Persia. He then moved with his brother where they continued their education in Belgium and London. His interest in the field of medicine inspired him to join Stony Brook School of Medicine. After his studies, he began his postgraduate training at Albert Einstein College of medicine as well as Montefiore Medical Centre.

Dr. David Samadi is dedicated to early detecting, diagnosing and treatment of cancer patients. He is precisely determined to improve the health of men by providing early diagnosis and treatment of prostate cancer. Through sharing medical information about cancer through radio show as well as his website, Samadi has educated people on how to lead a healthy life and how to cope up with cancer disease. He has also held a television show that has enabled him to share his knowledge with people. As a chief of robotic surgery at Lenox Hill Hospital, Dr. David Samadi spends most of his time-saving lives of prostate cancer patients. Currently, he is developing a more advanced technique of treating prostate cancer. He is aiming at making the procedure more efficient and less invasive to prevent the side effects such as impotence and incontinence which usually occur after prostate surgery. This will remove anxieties and doubt that men have on prostate surgery that makes them postpone them.

According to David, providing an excellent quality work is the most crucial part of any business person. He believes in a good team which is sufficient enough to share ideas with and implements them. He expresses that his team makes it possible for him to perform surgeries without delay. This is due to cooperation that exists between him and the team. Jealousy and envy is a cancer to him, and therefore he focuses on positivity and closeness. Dr. Samadi believes in a strict schedule as they make work run smoothly. He also treasures his team, and he treats them with respect as his own family. Effective communication with the patients is the key to gain trust from patients. According to Samadi, patients acquire a lot from him through communication, and he ensures that patients can contact him.As the chairman of Urology, David is also specialized in the treatment of urologic diseases, bladder and breast cancer. Up to now, he has been able to perform 7000 prostate cancer surgeries. With the advancement of cancer treatment and diagnosis, deaths that are related to cancer diseases will reduce.

Cure for Cancer with Clay Siegall and Seattle Genetics

Biotech is an area in science people didn’t know much about. But recent discoveries in genetics have put biotech on the map again. Large business parks house companies that specialise in biotech, and they keep growing. Seattle genetics is one such company. Steering this ship is their CEO Clay Siegall.

Making a Breakthrough in Research

Seattle Genetics mainly work with human antibodies. They perform research via shaping and modifying them to be used for medicinal purposes. The scientists are trying to find new ways natural antibodies can help people fight diseases. One of the biggest fights on their hands is cancer. If there could be a possibility of therapy that would destroy cancerous cells from within, it would be a massive breakthrough.

The company now provides around 900 jobs, and Clay Siegall proudly reveals their plans on expanding to add 200 more people to their roster. Their biggest market success is also their biggest health success. Adcetris is a drug that helps with Hodgkin lymphoma treatment. It’s currently in testing stages. But sales could take off quickly if the tests prove to be positive and successful.

Clay Siegall is ambitious and passionate about this line of work. He is not afraid of taking risks and in this 10 billion-dollar industry that is no small feat. He wants to make cancer drugs more accessible for people and develop new medicines to kill more aggressive forms of this disease. His ambitions are reflected in his leadership. Open and honest, he is a pleasant person to spend time with. He has the know-how and the business smarts that are crucial for this industry.

The Positive and the Smart

The market is becoming more demanding and competitive, so Clay Siegall often finds himself making quick decisions that can cost the company millions of dollars. However, if it helps people, he is not afraid to do it.

New research in cancer therapy is also crucial. Clay Siegall’s company is not yet breaking down any doors, but they are making progress. The combination of different drugs could help to create a cancer treatment that is less invasive and doesn’t leave people with the side-effects of nausea, weakness and fatigue.

He doesn’t take no for an answer and knows that you cannot win if you don’t lose from time to time. He has entrepreneur skills and the enthusiasm to keep going. He knows the market and follows his competitors’ work to see the progress drug companies are trying to make where cancer is concerned.